↓ Skip to main content

Dove Medical Press

Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
2 news outlets
twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
3 Mendeley
Title
Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study
Published in
Neuropsychiatric Disease and Treatment, August 2022
DOI 10.2147/ndt.s368740
Pubmed ID
Authors

Xuexue Bai, Xiaomin Liu, Jun Wen

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 33%
Unknown 2 67%
Readers by discipline Count As %
Neuroscience 1 33%
Unknown 2 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2022.
All research outputs
#2,126,200
of 25,392,582 outputs
Outputs from Neuropsychiatric Disease and Treatment
#261
of 3,131 outputs
Outputs of similar age
#45,528
of 431,954 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#4
of 57 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,954 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.